Skip to main content
. 2022 Nov 15;37(1):61–71. doi: 10.1038/s41375-022-01746-3

Table 2.

Total in vitro synergy scores between venetoclax in combination with hypomethylating or conventional chemotherapeutic agents.

graphic file with name 41375_2022_1746_Tab2_HTML.jpg